Screener
ADMA Biologics ADMA Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by ADMA Biologics in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: ADMA Biologics’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 5:16 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001140361-26-031445
FAQ
- What is ADMA Biologics's retained earnings?
- ADMA Biologics (ADMA) reported retained earnings of -$78.5M in Q2 2026.
- How has ADMA Biologics's retained earnings changed year-over-year?
- ADMA Biologics's retained earnings increased by 68.3% year-over-year, from -$247.46M to -$78.5M.
- What is the long-term trend for ADMA Biologics's retained earnings?
- Over 5 years (2020 to 2025), ADMA Biologics's retained earnings has grown at a -13.8% compound annual growth rate (CAGR), from -$340.47M to -$161.65M.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about ADMA Biologics's retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude